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Original papers Background Acute decompensated heart failure has an increasing incidence and poor prognosis, therefore, CA-125 may be a surrogate for both pathophysiological processes .
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The aim of the study was to assess the CA-125 changes in ADHF patients.
Method
The study group included 110 patients with 
Results
The baseline characteristics of the study group are presented in table 1. The mean age of the patients was 72±10 years, with male sex predominance -63% of the patients.
There were 35 (33%) subjects with obesity and the mean BMI was The 27.6±5.8 kg/m². m e a n LV E F w a s 3 7 % a n d t h e m e a n NT proBNP was -4049±2095 pg/mL.
CA-125 at admission was 53±33 U/mL, much higher than the known upper limit of 35 U/mL. There were no differences between CA-125 levels in males and females: 51±32 U/mL versus 55±34 U/mL (p=0.69).
There was a significant difference between NT-proBNP at admission in obese versus normoponderal patients 3207±1432 pg/mL ( versus 4457±2737 pg/mL (p=0.02)), which was maintained at discharge (1711±816 pg/mL versus 2674±1475 pg/mL (p=0.03)).
In the same time, the CA-125 did not show significant differences between obese and normoponderal subjects at admission (56±29 U/mL versus 51±20 U/mL (p=0.63)) and discharge (36±20 U/mL versus 33±16 U/mL (p=0.56)). The same data were observed in this study.
We identified higher levels of NT-proBNP and CA-125 in the subgroup of patients with reduced LVEF -heart failure compared to those with preserved LVEF -heart failure.
Also, the NT-proBNP and CA 125 levels were - Another study suggests that patients with elevated CA-125 levels would have a greater clinical benefit if they had an aggressive diuretic therapy .
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Conclusions
The wide availability of CA 125, its relatively - 
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